The DEGs obtained by comparing the sensitive and non-sensitive groups (as classified in this study) suggest that the main driver of sensitivity to FTY720 in CRC cells is associated with the sphingolipid pathway, represented by the CERS4, PPP2R2C, and BCL2 genes. This evidence concerns the gene BCL2 and colorectal carcinoma.